These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 29519793

  • 1. MRI Features Can Predict 1p/19q Status in Intracranial Gliomas.
    Lasocki A, Gaillard F, Gorelik A, Gonzales M.
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):687-692. PubMed ID: 29519793
    [Abstract] [Full Text] [Related]

  • 2. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A, Yolcu YU, Goyal A, Kerezoudis P, Brown DA, Graffeo CS, Goncalves S, Burns TC, Parney IF.
    Neurosurg Focus; 2019 Dec 01; 47(6):E13. PubMed ID: 31786548
    [Abstract] [Full Text] [Related]

  • 3. MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement.
    Kang KM, Song J, Choi Y, Park C, Park JE, Kim HS, Park SH, Park CK, Choi SH.
    Radiology; 2024 May 01; 311(2):e233120. PubMed ID: 38713025
    [Abstract] [Full Text] [Related]

  • 4. Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q Deletion.
    Lasocki A, Buckland ME, Molinaro T, Xie J, Gaillard F.
    AJNR Am J Neuroradiol; 2023 Nov 01; 44(11):1270-1274. PubMed ID: 37884300
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.
    Batchala PP, Muttikkal TJE, Donahue JH, Patrie JT, Schiff D, Fadul CE, Mrachek EK, Lopes MB, Jain R, Patel SH.
    AJNR Am J Neuroradiol; 2019 Mar 01; 40(3):426-432. PubMed ID: 30705071
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of IDH1-Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II Gliomas.
    Park YW, Han K, Ahn SS, Choi YS, Chang JH, Kim SH, Kang SG, Kim EH, Lee SK.
    AJNR Am J Neuroradiol; 2018 Apr 01; 39(4):693-698. PubMed ID: 29519794
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm.
    van der Voort SR, Incekara F, Wijnenga MMJ, Kapas G, Gardeniers M, Schouten JW, Starmans MPA, Nandoe Tewarie R, Lycklama GJ, French PJ, Dubbink HJ, van den Bent MJ, Vincent AJPE, Niessen WJ, Klein S, Smits M.
    Clin Cancer Res; 2019 Dec 15; 25(24):7455-7462. PubMed ID: 31548344
    [Abstract] [Full Text] [Related]

  • 11. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.
    Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Pöpperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C, Thon N.
    Neuro Oncol; 2012 Dec 15; 14(12):1473-80. PubMed ID: 23090986
    [Abstract] [Full Text] [Related]

  • 12. T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project.
    Patel SH, Poisson LM, Brat DJ, Zhou Y, Cooper L, Snuderl M, Thomas C, Franceschi AM, Griffith B, Flanders AE, Golfinos JG, Chi AS, Jain R.
    Clin Cancer Res; 2017 Oct 15; 23(20):6078-6085. PubMed ID: 28751449
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas.
    Peng X, Yishuang C, Kaizhou Z, Xiao L, Ma C.
    J Comput Assist Tomogr; 2019 Oct 15; 43(2):269-276. PubMed ID: 30371623
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MR textural analysis on T2 FLAIR images for the prediction of true oligodendroglioma by the 2016 WHO genetic classification.
    Rui W, Ren Y, Wang Y, Gao X, Xu X, Yao Z.
    J Magn Reson Imaging; 2018 Jul 15; 48(1):74-83. PubMed ID: 29140606
    [Abstract] [Full Text] [Related]

  • 17. Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI.
    Johnson DR, Diehn FE, Giannini C, Jenkins RB, Jenkins SM, Parney IF, Kaufmann TJ.
    AJNR Am J Neuroradiol; 2017 Apr 15; 38(4):678-684. PubMed ID: 28126746
    [Abstract] [Full Text] [Related]

  • 18. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T, Tominaga T.
    J Neurooncol; 2016 Sep 15; 129(3):505-514. PubMed ID: 27401154
    [Abstract] [Full Text] [Related]

  • 19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 20. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y, Xie Z, Zang Y, Zhang S, Gu D, Zhou M, Gevaert O, Wei J, Li C, Chen H, Du J, Liu Z, Dong D, Tian J, Zhou D.
    J Neurooncol; 2018 Nov 01; 140(2):297-306. PubMed ID: 30097822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.